IBM trades at an AI premium with no real AI growth behind it. The company forecast only 1% growth yet more than doubled from $150 to over $320 on AI hype, while its AI business is effectively non-existent. Its Q2 earnings warning came from consulting and infrastructure, not software, and the stock has fallen back to its May level around $220. x.com  x.com  x.com 

IBM is a valuation trap, with a high-conviction sell target of $200 by December 2026 as its multiple compresses toward its historical average. It lags in AI and quantum, its premium P/E lacks the structural growth to justify it, and its CY26 EPS estimate of $12.35 is under threat. A macro slowdown could push enterprises to cut nice-to-have transformation projects, and missing hyped quantum milestones would speed a rerating as Google and Microsoft pull ahead. x.com  x.com 

IBM's second-quarter miss looks like a timing issue rather than AI taking over software, with valuation offering support. Shares fell after management cited clients shifting capex to memory and hardware amid supply constraints and price hikes, plus poor execution on closing deals. It is a rare miss for CEO Arvind Krishna. The stock could be dead money for a while. x.com 

IBM is extremely expensive, and its latest announcement adds caution: enterprises are prioritizing hardware and memory purchases, which pressures software spending. Quantum computing is a distant option, software is too small a part of the business to drive upside, and the stock carries a significant Trump premium. The same shift supports even stronger conviction in semiconductors and memory. x.com 

Hardware is the new software as clients redirect capex toward supply-constrained servers, storage and memory, benefiting Dell and SanDisk. IBM fell 25% after saying clients shifted late-June capex toward those purchases ahead of expected price increases, a reprioritization bigger than it anticipated. x.com 

IBM looks attractive because investors are treating a timing slip like a demand collapse. x.com 

IBM is not worth buying unless it reinvents itself. It has some dominant businesses, but since the financial crisis it has relied on financial engineering rather than real innovation. Even buying at the Covid low or the 2022 low produced a poor return, cushioned only by a roughly 5% dividend. x.com  x.com  x.com 

IBM remains bearish on trend heading into earnings, which will be a damage report rather than a preview. It already pre-warned on July 15 with preliminary results well below estimates, BofA cut its target to $280, and the stock is down about 34%. Because much of the bad news is already out, a bounce is possible if it resets the bar and stops the bleeding. x.com 

IBM's record one-day drop, on pace to surpass its 1987 Black Monday decline, is the biggest overreaction since Netflix's near-40% plunge in 2022. IBM's CEO said only a few large capex deals in mainframe and its associated software were paused near quarter-end, not a widespread problem, and that IBM does not see its software being disrupted by AI at all. x.com  x.com 

Hardware is squeezing software as enterprises redirect budgets to scarce servers, GPUs and storage, favoring semiconductors over software. IBM's Q2 revenue of $17.2B missed its $17.9B target, and its CEO said clients moved software and IT consulting budgets to secure rising-priced hardware. Microsoft, ServiceNow and Salesforce face near-term pressure while Dell and Micron benefit. Aehr Test's beat and raised guidance counter claims the chip cycle is dead. x.com